Volume 7, Issue 1, March 2019, Page: 24-29
Prevalence and Profile of Migraine Patients in Brazzaville, Congo
Ossou-Nguiet Paul Macaire, Department of Medicine, Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Brazzaville, Congo; Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Mpandzou Ghislain Armel, Department of Medicine, Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Brazzaville, Congo; Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Ongoly Ikora Héloïse Stéphanie, Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Diatewa Josué Euberma, Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Obondzo Aloba Karen Lise Charmel, Department of Medicine, Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Brazzaville, Congo; Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Motoula Latou Dinah Happhia, Department of Neurology, University Hospital of Brazzaville, Brazzaville, Congo
Received: Mar. 14, 2019;       Accepted: Apr. 27, 2019;       Published: Jun. 18, 2019
DOI: 10.11648/j.ajpn.20190701.15      View  120      Downloads  13
Abstract
Migraine is a chronic disease evolving through recurrent seizures; it constitutes a frequent reason of consultation in neurology. Epidemiological data on migraine in the world are available, but no study has been conducted in general population in Congo. To determinate the prevalence of migraine in population of Brazzaville, we conducted a prospective cross-sectional, door-to-door study. This study took place from March 1st to July 31st, 2018, in the city of Brazzaville. Regarding all subjects over 18 years old, living in Brazzaville for over ten years. The statistical analysis was performed using SPSS 20.0 software for Mac. The prevalence of migraine was 11,3% in Brazzaville, with 6% definite migraine and 5,3% of probable migraine. Women are more affected than men respectively 63,5% and 36,5%. Migraine without aura is more common than migraine with aura. Migraine is a public health problem because of its prevalence. Its affects the young adult and more preferably the woman The knowledge of the epidemiology of migraine in Brazzaville will lead to better awareness-raising actions.
Keywords
Migraine, Prevalence, Brazzaville
To cite this article
Ossou-Nguiet Paul Macaire, Mpandzou Ghislain Armel, Ongoly Ikora Héloïse Stéphanie, Diatewa Josué Euberma, Obondzo Aloba Karen Lise Charmel, Motoula Latou Dinah Happhia, Prevalence and Profile of Migraine Patients in Brazzaville, Congo, American Journal of Psychiatry and Neuroscience. Vol. 7, No. 1, 2019, pp. 24-29. doi: 10.11648/j.ajpn.20190701.15
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33 (9): 629-808.
[2]
Dodick DW, Migraine. http: www.thelancet.com Published online March 6, 2018 http: //dx.doi.org/10.1016/S0140-6736(18)30478-1.
[3]
World Health Organization. Headache disorders, FactsheetN277.2016. http: //www.who.int/mediacentre/factsheets/fs277/en/. consultésept 2018.
[4]
Ahmed MAK, Haddad M, Kouassi B, Ouhabi H, Serrie A. Consensus formalisé: recommandations de pratiques cliniques pour la prise en charge de la migraine du patient adulte africain. Pan AfricanMedical Journal. 2016; 24: 81.
[5]
Lanteri-Minet M, Valade D, Geraud G, Lucas C, Donnet A. Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et l’enfant: aspects cliniques et économiques 2002. Revue Neurologique. 2013; 169: 14-29.
[6]
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38 (1): 1-211.
[7]
Marcelo E, Bigal ME, Richard B. Lipton RB. The Epidemiology, Burden, and Comorbidities of Migraine. Neurology clinic 2009; 27 (2): 321-34.
[8]
Woldeamanuel YW, Robert P. Cowan Migraine affect 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. Journal Neurological Science. 2016; 372: 307-15..
[9]
Ossou-Nguiet PM, Gnonlonfoun D, Matali E, Obondzo-Aloba K, Nguienia D, Banzouzi L, et al. Drug overuse and chronic headaches in Brazzaville: Patients profile and therapeutic itinerary. Cephalalgia. 2015; 35 (6s): 106.
[10]
Kube Technologie2017.commune de Brazzaville, Congo: les arrondissements. «http:www.brazzaville.cg/fr». consulté en novembre 2017
[11]
Atlas des populations et pays du monde en 2017. http:www.populationdata.net/pays/congo. Consulté en janvier 2018
[12]
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
[13]
GBD Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018; 17: 954-76.
[14]
El-Sherbiny NA, Masoud M, Shalaby NM, Shehata HS. Prevalence of primary headache disorders in Fayoum Governorate, Egypt. Journal of Headache Pain. 2015; 16: 85.
[15]
Mbewe E, Zairemthiama P, Yeh H-H, Paul R, Birbeck GL, Steiner TJ. The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. Journal of Headache and Pain. 2015; 16: 30.
[16]
Gururaj G, Kulkarni GB, Rao GN, Subbakrishna DK, Stovner LJ, Steiner TJ. Prevalence and Sociodemographic Correlates of Primary Headache Disorders: Results of a Population-based Survey from Bangalore, India. Indian Journal of Public Health. 2014; 58 (4): 241-8.
[17]
Zebenigus M, Tekle-Haimanot R, Worku DK, Thomas H, Steiner TJ. The prevalence of primary headache disorders in Ethiopia. Journal of Headache and Pain. 2016; 17: 110.
[18]
Adoukonou TA, Houinato DS, Adjien KC, Gnonlonfoun D, Avode DG, Preux P-M. Prévalence de la migraine dans une population de travailleurs à Cotonou au Bénin. African Journal of Neurological Sciences. 2009; 28 (1): 16-22.
[19]
Maiga Y, Soumaila B, Drissa K, Yacouba C, Sara D, Lala C et al. La migraine en milieu scolaire à Gao au Mali. African Journal of Neurological Sciences. 2011; 30 (2): 49-55.
[20]
Adoukonou T, Tognon-Tchegnonsi T, Kouna P, Alabi A, Houinato D, Preux PM. Prevalence of migraine among university students at Parakou, Benin: A cross-sectional study. World Journal of Neurosciences. 2014; 4: 18-24.
[21]
Manandhar K, Risal A, Steiner TJ, Holen A, Linde M. The prevalence of primary headache disorders in Nepal: a nationwide population-based study. Journal of Headache Pain. 2015; 16: 95.
[22]
Phanthumchinda K, Sithi-Amorn C. Prevalence and clinical features of migraine: a community survey in Bangkok, Thailande. Headache: Journal of Head and Face Pain. 1999; 29 (9): 594-97.
[23]
Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lantéri–Minet M, Lucas C, et al. Prevalence and clinicalcharacteristics of migraine in France. Neurology. 2002; 59: 232-7.
[24]
Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Steiner TJ. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. European Journal of Neurology. 2014; 21: 758-65.
[25]
Streel S, Donneau AF, Hoge A, Albert A, Schoenen J, Guillaume M. One-year prevalence of migraine using a validated extended French version of the ID MigraineTM: A Belgian population-based study. Review of Neurology. 2015; 171: 707-14.
[26]
Katsarava K, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M et al.Primary headache disorders in the Republic of Georgia: Prevalence and risk factors. Neurology. 2009; 73: 1796–803.
[27]
Stovner LJ, Al Jumah M, Birbeck GL, Gururaj G, Jensen R, Katsavara Z et al. The methodology of population survey of headache prevalence, burden and cost: Principles and recommandations from the Global Campaign against Headache. Journal of Headache Pain. 2014; 15: 5.
[28]
Özdemir G, Aygül R, Demir R, Özel L, Ertekin A, Ulvï H. Migraine prevalence, disability, and sociodemographic properties in the eastern region of Turkey: a population-based door-to-door survey. Turk Journal of Medical Sciences. 2014; 44: 624-9.
[29]
Charles A. The Migraine Aura. Continuum: Lifelong learning in Neurology. 2018; 24 (4): 1009-22.
[30]
Solotareff L, Cuvellier JC, Duhamel A, Vallée L, Tich SNT. Trigger factors in childhood migraine: A prospective clinic-Based Study from north of France. Journal of Child Neurology. 2017; 32 (8): 754-8.
[31]
Schroeder RA. Brandes J, Buse DC, Calhoun A, Eikermann-Haeter K, Golden K. Sex and gender differences in migraine-Evaluating knowledge gaps. Journal of Women’s Health. 2018; 27 (8): 965-73.
[32]
Chai NC, Peterlin BL, Calhoun AH. Migraine and oetrogen. Current Opinion Neurology. 2014; 27 (3): 315.
[33]
Cappy H, Lucas C, Catteau-Jonard S, Robin G. Migraine and contraception. Gynécologie Obstétrique & Fertilité. 2015; 43: 234-41.
[34]
Antonaci F, Voiticovschi-Iosob C, Di Stefano AL, Galli F, Ozge A, Balottin U. The evolution of headache from childhood to adulthood: A review of literature. Journal of Headache Pain. 2014; 15: 15
[35]
Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache. 2018; 58: 496-505.
[36]
Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K et al. Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps. Journal of Women’s Health. 2018; 27 (8): 965-73.
[37]
Victor T, Hu X, Campbell J, Buse D, Lipton R. Migraine prevalence by age and sex in United States: A life-span study. Cephalalgia. 2010; 30: 1065-72.
[38]
Maiga Y, Soumaïla B, Cissoko L N, Sangaré M, Diallo SH, Diallo S, et al. Epidemiology of migraine among students in Mali. Ensci. 2017, doi:10.1016/j.ensci.2017.04.001.
[39]
Adoukonou T, Houinato D, Kankouan J, Makoutode M, Paraiso M, Tehindrazanarivelo A. et al. Migraine Among University Students in Cotonou (Benin). Headache. 2009; 49: 887-93.
[40]
Henry P. Comprendre et combattre la migraine, 2e édition Flammarion, Paris, 2003.
[41]
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of Migraine Headache in the United States. Relation to Age, Income, Race, and Other Sociodemographic Factors. JAMA. 1992; 267: 64-9.
[42]
Russell MB, Iselius L, Olesen J. Migraine without aura an Migraine with aura are herited disorders. Cephalalgia. 1996;16(5):305-9.
[43]
Pelzer N, Louter MA, van Zwet EW, Nyholt DR, Ferrari MD, van den Maagdenberg AMJM et al. Linking migraine frequency with family story of migraine. Cephalalgia. 2018; 0 (0): 1-8.
[44]
MacGregor EA. Migraine clinic. American College of Physicians. Annals of Internal Medicine. 2017:50-64. doi: 10.7326/AITC201704040.
Browse journals by subject